Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Dual-Task Training.
- Who it may be relevant to
- Registry conditions: Parkinson Disease (PD). Basic parameters: 40 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of Dual-Task Training on Upper Extremity Function and Muscle Thickness in Parkinson's Disease
Overview
The goal of this clinical trial is to investigate the effects of dual-task training on upper extremity function and muscle thickness in individuals with Parkinson's disease. The main questions it aims to answer are: Does dual-task training improve upper extremity function in individuals with Parkinson's disease? Does dual-task training lead to changes in upper extremity muscle thickness measured by ultrasonography? Researchers will compare a dual-task training group with a control group receiving routine care to determine whether 8 weeks of dual-task training results in greater improvements in upper extremity outco Participants will: complete baseline and post-intervention assessments of upper extremity function, muscle thickness, grip strength, and pinch strength be assigned to either a control group or a dual-task training group receive dual-task training 3 days per week for 8 weeks if assigned to the intervention group
Interventions
- Behavioral Dual-Task Training
Dual-task training will be applied 3 times per week for 8 weeks, with each session lasting 60 minutes. The program combines motor tasks (such as peg placement, object manipulation, bilateral coordination, and mobility tasks) with simultaneous cognitive tasks (such as backward counting, category-based word generation, and memory tasks).
Primary outcome measures
- Upper Extremity Function [Time frame: Baseline and 8 weeks]
- Upper Extremity Muscle Thickness [Time frame: Baseline and 8 weeks]
- Hand Grip Strength [Time frame: Baseline and 8 weeks]
- Pinch Strength [Time frame: Baseline and 8 weeks]
Eligibility criteria
Inclusion criteria
- Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
- Modified Hoehn and Yahr stage 2 to 3
- No medication or dosage change within the last 6 months
- Cognitive capacity sufficient to understand and follow instructions, defined as Montreal Cognitive Assessment score ≥21
- Voluntary participation with written informed consent
Exclusion criteria
- Atypical or secondary parkinsonism
- Advanced orthopedic condition affecting the upper extremity
- Surgery, trauma, or immobilization involving the upper extremity within the last 6 months
- Wound or dermatological condition preventing upper extremity ultrasonographic evaluation
- Severe visual or hearing loss
- Severe depression, psychosis, or communication difficulty
- Any additional health problem preventing regular participation in the study
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Turkey (Türkiye) · 1 center
- Hacettepe University — Ankara
Identifiers
NCT: NCT07536542 · f57111e3114a4f65